Drawing for NEPHROLYTIX

USPTO serial 79324325

NEPHROLYTIX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
CARR, PATRICK C
Law office
TMO LAW OFFICE 125 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with NEPHROLYTIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Chemical reagents for medical or veterinary purposes; clinical diagnostic reagents; diagnostic agents for medical use; diagnostic agents for pharmaceutical use; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations and materials; diagnostic preparations for medical and veterinary use; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic reagents for medical use; diagnostic reagents for medicinal use; diagnostic substances for medical use; diagnostic testing materials for medical use; immunoassay reagents for medical use; in vitro diagnostic preparations for medical use; indicators for medical diagnosis; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic test strips; pharmaceutical preparations for the treatment of kidney diseases; reagents and media for medical and veterinary diagnostic purposes; reagents for blood grouping [for medical purposes]; reagents for in-vitro laboratory use [for medical purposes]; reagents for medical use; reagents for use in diagnostic tests [for medical purposes]; reagents for use in diagnostic tests [for veterinary purposes]; veterinary diagnostic reagentsSECTION 70 - CANCELLED—
010Apparatus for blood analysis; apparatus for blood analysis [for medical use]; apparatus for blood tests [for medical use]; apparatus for carrying-out diagnostic tests for medical purposes; apparatus for taking blood; apparatus for taking blood samples; blood centrifuging tubules [for medical use]; blood collection tubes for medical use; blood testing apparatus; blood testing equipment; capillary tubes for delivering reagents; diagnostic apparatus for medical purposes; diagnostic instruments for medical use; diagnostic, examination, and monitoring equipment for medical purposes; filters for blood and blood components for medical purposes; medical diagnostic apparatus for medical purposes; medical diagnostic instruments; testing instruments for medical diagnostic purposesSECTION 70 - CANCELLED—
042Analytical laboratory services; biological laboratory services; biological research laboratory services; blood analysis services; chemical laboratory services; chemical research laboratory services; consultancy relating to laboratory testing; design and development of medical diagnostic apparatus; design of diagnostic apparatus; development of diagnostic apparatus; laboratory analysis; laboratory research; laboratory research services relating to pharmaceuticals; laboratory services; laboratory services for analytical testing; laboratory testing; laboratory testing of materials; laboratory testing services; medical research laboratory services; platforms for artificial intelligence as software as a service [SaaS]; providing artificial intelligence computer programs on data networks; rental of laboratory apparatus and instruments; research and development in the field of diagnostic preparations; research in the field of artificial intelligence; research laboratory services; scientific laboratory services; software as a service [SaaS] featuring computer software platforms for artificial intelligence; hosting services, software as a service, and rental of software; software development, programming and implementation; maintenance of data processing software; diagnosing computer hardware problems using softwareSECTION 70 - CANCELLED—
044Laboratory analysis services relating to the treatment of persons; medical analysis for the diagnosis and treatment of persons; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services relating to the treatment of persons provided by a medical laboratory; medical diagnostic services; medical laboratory services for the analysis of blood samples taken from patients; medical laboratory services for the analysis of samples taken from patients; medical services for the diagnosis of conditions of the human body; medical services relating to the removal, treatment and processing of human blood; medical testing for diagnostic or treatment purposes; medical testing services relating to the diagnosis and treatment of disease; performing diagnosis of diseases; providing online medical record services other than dentistry; services for the testing of bloodSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 3, 2023FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 7, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 7, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 29, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 29, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 20, 2023DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Feb 19, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 7, 2022MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 7, 2022ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 16, 2022RFNTREFUSAL PROCESSED BY IB—
Apr 26, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 26, 2022RFRRREFUSAL PROCESSED BY MPU—
Mar 16, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 15, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 8, 2022DOCKASSIGNED TO EXAMINER—
Nov 9, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 5, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 28, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance